Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Cervical Cancer vaccine wins pharma “Nobel Prize”


MEDIA RELEASE
24 November, 2008

Cervical Cancer vaccine wins “Nobel Prize” of the pharmaceutical world.

GARDASIL®, the vaccine used in the New Zealand cervical cancer immunisation programme, has won the prestigious 2008 International Galien Prize, according to Mike Taylor, New Zealand Country Manager for CSL Biotherapies NZ Ltd.

“An independent jury of clinicians, toxicologists and pharmacologists has awarded GARDASIL the pharmaceutical equivalent of a Nobel Prize” he says.

“The award shows GARDASIL is recognised, beyond doubt, as a breakthrough in the fight against cervical cancer” Mike Taylor said.

And it seems young women in New Zealand already agree with this view. Since the roll-out of the publicly funded vaccination programme in September 2008, higher than expected numbers of 17 and 18 year olds, have headed straight to their GP to get the first shot of the vaccine that will protect them against cervical cancer.

However it is important for girls to know that it’s not just the first shot that is important. The key to having the best possible protection against cervical cancer is ensuring that young women come back for their second and third shots.

To help the girls remember to come back for their second and third shots CSL Biotherapies Ltd developed a quick and easy ‘Remind Me’ compliance programme that alerts young women, by email and text when their remaining shots are due. This GARDASIL ‘Remind Me’ programme has been extremely well received with up 80% of girls joining up to the compliance programme.

While the publicly-funded immunisation programme currently focuses on young women born in 1990 and 1991, a school-based vaccination programme for girls aged 12 to 18 will commence in early 2009.

GARDASIL is the only four-type (6, 11, 16, 18) human papillomavirus (HPV) vaccine. GARDASIL also protects against cervical, vulvar and vaginal pre-cancer, and genital warts caused by HPV types 6, 11, 16 and 18. These four types together cause the vast majority of HPV-related genital diseases.

GARDASIL is authorised for use in 107 countries and is widely implemented with 36 million doses distributed worldwide. These figures reflect the strong endorsement by experts, regulators, health authorities, physicians, parents and daughters.

ENDS


www.yourbestshot.co.nz

About CSL Biotherapies Limited
CSL Biotherapies Limited is a global, specialty biopharmaceutical company that develops, manufactures and markets products to treat and prevent serious human medical conditions. Innovation and new product development for unmet medical needs continue to drive CSL Biotherapies growth. CSL Biotherapies (NZ) Limited was set up in New Zealand in 1992 to provide a range of vaccines and medications to the New Zealand population. Over the past 16 years CSL Biotherapies (NZ) Limited has also held contracts with the NZ Government to supply vaccines ranging from influenza, tetanus, diphtheria and combination vaccines.

About CSL Biotherapies and Merck & Co
Fundamental technology, contributing to the development of GARDASIL, was discovered in 1991 at the University of Queensland by Professor Ian Frazer and Dr Zhou in collaboration with CSL Biotherapies Limited. In 1995 CSL Biotherapies licensed this technology to Merck & Co., Inc. - parent company of Merck Sharp & Dohme New Zealand (MSD NZ). Merck then undertook an extensive clinical trial programme leading to the development of GARDASIL. CSL Biotherapies markets GARDASIL in New Zealand and Australia. Merck & Co., Inc. markets the vaccine in the rest of the world. MSD NZ has also contributed to the international research efforts for the vaccine by co-coordinating a Phase III clinical trial, with sites in Auckland and Christchurch.

GARDASIL® is a registered trademark of Merck and Co Inc., Whitehouse Station, N.J, USA.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Auckland Transport: Successful Bridge Repair Opens Two Additional Lanes To Traffic

The opening of two additional lanes on the Auckland Harbour Bridge this morning will help relieve some motorway congestion for motorists heading home to the North Shore tonight. More>>

ALSO:

Statistics New Zealand: COVID-19 Sees Record 12.2 Percent Fall In New Zealand’s Economy

Gross domestic product (GDP) fell by 12.2 percent in the June 2020 quarter, the largest quarterly fall recorded since the current series began in 1987, as the COVID-19 restrictions in place through the quarter impacted economic activity, Stats NZ said ... More>>

ALSO:

Climate: Scientists Release ‘Blueprint’ To Save Critical Ecosystems And Stabilize The Earth’s Climate

A group of scientists and experts produced the first comprehensive global-scale analysis of terrestrial areas essential for biodiversity and climate resilience, totaling 50.4% of the Earth's land. The report was published in Science Advances ... More>>

ALSO:

MPI: Independent Review Launched Into Assurances For Safe Transport Of Livestock By Sea

The Ministry for Primary Industries (MPI) has launched an independent review of the assurances it receives for the safe transport of livestock by sea. MPI Director-General Ray Smith says Mike Heron QC has been appointed to lead the review, which is expected ... More>>

ALSO:


Computers: New Zealand PC Market Grows Nearly 40% Due To Work From Home Demand

COVID-19 had large impacts on demand for PCs as businesses prepared for lockdowns by purchasing notebooks to mobilise their workforce. In the second quarter of 2020, New Zealand's Traditional PC market experienced a 39.7% year-on-year (YoY) growth ... More>>

ALSO:


RetailNZ: Retail Sales And Confidence Rebound After Second Lockdown Lifts

A new Retail NZ Retail Radar report show retailer sales have improved in through September as the second wave of COVID-19 restrictions lifted. Sales were up 20 per cent and 45 per cent of retailers said that their sales improved on the same time ... More>>

University Of Auckland: Whale-Watching By Satellite – Follow Their Travels Online

Scientists have successfully attached satellite tracking tags to six New Zealand southern right whales, or tohorā, and are inviting the public to follow the whales’ travels online. Part of a major research project involving the University of Auckland ... More>>

Commerce Commission: Kiwibank Admits System Failures And Agrees To Pay Customers $5.2 Million

Kiwibank has entered into a settlement agreement with the Commerce Commission after reporting that it failed to have in place robust home loan variation disclosure policies, procedures and systems. In a settlement dated 27 August 2020, Kiwibank admitted that ... More>>

Ministry of Health: Public Transport Distancing Requirements Relaxed

Physical distancing requirements on public transport have been reviewed by the Ministry of Health to determine whether they are still required at Alert Level 2 (or below). The Ministry’s assessment is that mandatory face covering and individuals tracking ... More>>

ALSO:

NZHIA: New Zealand Hemp Industry Set To Generate $2 Billion Per Annum And Create 20,000 Jobs

A new report says a fully enabled hemp industry could generate $2 billion in income for New Zealand by 2030, while also creating thousands of new jobs. Written by industry strategist Dr Nick Marsh, the report has prompted calls from the New Zealand Hemp ... More>>

ALSO:

Stats NZ: One In 14 Employed People Report High Risk Of Losing Jobs

About one in 14 workers say they expect to lose their job or business by mid-2021, Stats NZ said today. A survey of employed people in the June 2020 quarter showed 7 percent felt there was a high or almost certain chance of losing their job or business ... More>>